Role of CYP17 and CYP19 polymorphisms in idiopathic recurrent miscarriages among South Indian women

Reproductive BioMedicine Online

Volumn 14, Issue 3, 2007, Pages 341-347

  Suryanaryana, Venkata V ^a   Rao, Lakshmi ^a   Kanakavalli, Murthy K ^a   Padmalatha, Venkata V ^a   Deenadayal, Mamata ^b   Singh, Lalji ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b Infertility Institute and Research Centre   (India)

Author keywords

CYP17; CYP19; Polymorphisms; Recurrent miscarriages

Indexed keywords

AROMATASE; CYTOCHROME P450 17;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDIA; INTRON; MAJOR CLINICAL STUDY; PATHOGENESIS; RECURRENT ABORTION;

EID: 33947503083     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60877-2     Document Type: Article

References (28)

1. Ahsan H, Whittemore AS, Chen Y et al. 2005 Variants in estrogen-biosynthesis genes CYP17 and CFP19 and breast cancer risk: a family-based genetic association study. Breast Cancer Research 7, R71-R81.
2. Albrecht ED, Aberdeen GW, Pepe GJ 2000 The role of estrogen in the maintenance of primate pregnancy. American Journal of Obstetrics and Gynecology 182, 432-438.
3. Brosens J, Verhoeven H, Campo R et al. 2004 High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Human Reproduction 19, 352-356.
4. Feigelson HS, Shames LS, Pike MC et al. 1998 Cytochrome P450c17a gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Research 58, 585-587.
5. Feigelson HS, Coetzee GA, Kolonel LN et al. 1997 A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Research 57, 1063-1065.
6. Haddad-Filho J, Cedenho AP, Katz SG 2007 Endometrial expression of IL-1Rtl in patients undergoing miscarriage or unsuccessful IVF cycles. Reproductive BioMedicine Online 14, 117-124.
7. Haiman CA, Hankinson SE, Spiegelman D et al. 1999 The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Research 59, 1015-1020.
8. Kado N, Kitawaki J, Obayashi H et al. 2002 Hasegawa G, Nakamura N, Yoshikawa T, Honjo H. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Human Reproduction 17, 897-902.
9. Kay C, Jeyendran RS, Coulam CB 2006 p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure Reproductive BioMedicine Online 13, 492-496.
10. Madon PF, Athalye AS, Parikh FR 2005 Polymorphic variants on chromosomes probably play a significant role in infertility Reproductive BioMedicine Online 11, 726-732.
11. Miller SA, Dykes DD, Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16, 1215.
12. Mlynarcikova A, Fickova M, Scsukova S 2005 Ovarian intrafollicular processes as a target for cigarette smoke components and selected environmental reproductive disruptors. Endocrine Regulations 39, 20-31.
13. Moran FM, Vandevoort CA, Overstreet JW et al. 2003 Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion clue to decreased 17βhydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology 144, 467-473.
14. Moudgal NR, Shetty G, Selvaraj N, Bhatnagar AS 1996 Use of a specific aromatase inhibitor for determining whether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo development. Journal of Reproduction and Fertility Supplement 50, 69-81.
15. Otani T, Roche M, Mizuike M et al. S 2006 Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with a history of recurrent miscarriage and unsuccessful pregnancies. Reproductive BioMedicine Online 13, 869-874.
16. Payne AH, Hales DB 2004 Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Reviews 25, 947-970.
17. Petry CJ, Ong KK, Michelmore KF et al. 2005 Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Human Reproduction 20, 1837-1843.
18. Quenby S, Anim-Somuah M, Kalumbi C et al. 2007 Different types of recurrent miscarriage are associated with different patterns of adhesion molecule expression in endometrium. Reproductive BioMedicine Online 14, 224-234.
19. Sata F, Yamada H, Yamada A et al. 2003 A polymorphism In the CYP17 gene relates to the risk of recurrent pregnancy loss. Molecular Human Reproduction 9, 725-728.
20. Snyder GD, Holmes RW, Bates JN, Van Voorhis BJ 1996 Nitric oxide inhibits aromatase activity: mechanisms of action. Journal of Steroid Biochemistry and Molecular Biology 58, 63-69.
21. Szyllo K, Smolarz B, Romanowicz-Makowska H, Kulig A 2006. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients. Polish Journal of Pathology 57, 35-40.
22. Travis RC, Churchman M, Edwards SA et al. 2004 No association of polymorphisms in CYP17, CYP19 and HSD17-B1 with plasma estradiol concentrations in 1090 British women. Cancer Epidemiology Biomarkers and Prevention 13, 2282-2284.
23. Tworoger SS, Chubak J, Aiello EJ et al. 2004 Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiology Biomarkers and Prevention 3, 94-101.
24. Urbanek M, Legro RS, Driscoll DA et al. 1999 Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proceedings of National Academy of Science of the USA 96, 8573-8578.
25. Weissgerber TL, Wolfe LA 2006 Physiological adaptation in early human pregnancy: Adaptation to balance maternal-fetal demands. Applied Physiology, Nutrition and Metabolism 31, 1-11.
26. Witt BR, Wolf GC, Wainwright CJ et al. 1990 Relaxin, CA-125, progesterone, estradiol, Schwangerschaft protein, and human chorionic gonadotropin as predictors of outcome in threatened and nonthreatened pregnancies. Fertility and Sterility 53, 1029-1036.
27. Woodhouse AJ, Cooke GM 2004 Suppression of aromatase activity in vitro by PCBs 28 and 105 and Aroclor 1221. Toxicology Letters 152, 91-100.
28. Woods NF, Mitchell ES, Tao Y et al. 2006 Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause Sep 12; [Epub ahead of print].